Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

By Robb M. Stewart

Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.

The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex.

Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs.

GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion.

Write to Robb M. Stewart at robb.stewart@wsj.com